Details
Product Name in the RMS: Bortezomib W&H
MR Number: IS/H/0438/001
Date of outcome: 12.06.2015
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Known Active Substance Initial Application Generic Chemical Substance Prescription Only |
Active Substances |
BORTEZOMIB 3,5 mg |
Form | POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION/INFUSION |
MA Holder in the RMS | LOGENEX Pharm GmbH |
RMS | Iceland |
Date of last change | 26.01.2021 |
ATC-Code |
L01XX32 Bortezomib |
CMS Country | Domestic Product Name |
---|---|
Austria | |
Belgium | Bortezomib B-Medical 3,5mg poeder voor oplossing voor injectie |
Croatia | Bortezomib Alpha-Medical 3,5 mg prašak za otopinu za injekciju |
Cyprus | Bortezomib Ledpharm 3.5mg powder for solution for injection |
Germany | Bortezomib Ribosepharm 3,5 mg Pulver zur Herstellung einer Injektionslösung |
Italy | |
Latvia | Bortezomib PharmIdea 3,5 mg pulveris injekciju šķīduma pagatavošanai |
Netherlands | |
Portugal | |
Slovak Republic | Bortezomib Pharmevid 3,5 mg prášok na injekčný roztok |
Spain |
Documents | |
---|---|
PAR: | IS_H_0438_001_PAR.pdf (15.10.2019) |
PARSummary: | IS_H_0438_001_PARSummary.pdf (15.10.2019) |